Literature DB >> 30099988

Structural Basis for MARK1 Kinase Autoinhibition by Its KA1 Domain.

Ryan P Emptage1, Mark A Lemmon2, Kathryn M Ferguson2, Ronen Marmorstein3.   

Abstract

The kinase associated-1 (KA1) domain is found at the C-terminus of multiple Ser/Thr protein kinases from yeast to humans, and has been assigned autoinhibitory, membrane-binding, and substrate-targeting roles. Here, we report the crystal structure of the MARK1 kinase/UBA domain bound to its autoinhibitory KA1 domain, revealing an unexpected interface at the αD helix and contacts with both the N- and C-lobes of the kinase domain. We confirm the binding interface location in kinetic studies of variants mutated on the kinase domain surface. Together with other MARK kinase structures, the data implicate that the KA1 domain blocks peptide substrate binding. The structure highlights the kinase-specific autoinhibitory binding modes of different KA1 domains, and provides potential new avenues by which to intervene therapeutically in Alzheimer's disease and cancers in which MARK1 or related kinases are implicated.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-terminal domain; MARK1; Tau protein; activation segment; autoinhibition; inhibitory mechanism; serine/threonine protein kinase; structural biology; αD helix

Mesh:

Substances:

Year:  2018        PMID: 30099988      PMCID: PMC6092042          DOI: 10.1016/j.str.2018.05.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  28 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Structural variations in the catalytic and ubiquitin-associated domains of microtubule-associated protein/microtubule affinity regulating kinase (MARK) 1 and MARK2.

Authors:  Alexander Marx; Chanakya Nugoor; Jens Müller; Saravanan Panneerselvam; Thomas Timm; Matthias Bilang; Efstratios Mylonas; Dmitri I Svergun; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2006-06-27       Impact factor: 5.157

Review 5.  Revisiting protein kinase-substrate interactions: Toward therapeutic development.

Authors:  Paulo Sérgio L de Oliveira; Felipe Augusto N Ferraz; Darlene A Pena; Dimitrius T Pramio; Felipe A Morais; Deborah Schechtman
Journal:  Sci Signal       Date:  2016-03-22       Impact factor: 8.192

6.  Molecular determinants of KA1 domain-mediated autoinhibition and phospholipid activation of MARK1 kinase.

Authors:  Ryan P Emptage; Mark A Lemmon; Kathryn M Ferguson
Journal:  Biochem J       Date:  2016-11-22       Impact factor: 3.857

7.  Microtubule-affinity regulating kinase (MARK) is tightly associated with neurofibrillary tangles in Alzheimer brain: a fluorescence resonance energy transfer study.

Authors:  J Y Chin; R B Knowles; A Schneider; G Drewes; E M Mandelkow; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  Intramolecular autoinhibition of checkpoint kinase 1 is mediated by conserved basic motifs of the C-terminal kinase-associated 1 domain.

Authors:  Ryan P Emptage; Megan J Schoenberger; Kathryn M Ferguson; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

Review 10.  Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy.

Authors:  Gwenola Manic; Florine Obrist; Antonella Sistigu; Ilio Vitale
Journal:  Mol Cell Oncol       Date:  2015-02-23
View more
  6 in total

1.  Kinase Activity of PAR1b, Which Mediates Nuclear Translocation of the BRCA1 Tumor Suppressor, Is Potentiated by Nucleic Acid-Mediated PAR1b Multimerization.

Authors:  Hiroko Nishikawa; Priscillia Christiany; Takeru Hayashi; Hisashi Iizasa; Hironori Yoshiyama; Masanori Hatakeyama
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

2.  Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinib.

Authors:  Mingsong Shi; Lun Wang; Kongjun Liu; Yong Chen; Mengshi Hu; Linyu Yang; Jun He; Lijuan Chen; Dingguo Xu
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

3.  Structural basis for recruitment of the CHK1 DNA damage kinase by the CLASPIN scaffold protein.

Authors:  Matthew Day; Sarah Parry-Morris; Jack Houghton-Gisby; Antony W Oliver; Laurence H Pearl
Journal:  Structure       Date:  2021-03-30       Impact factor: 5.006

4.  Growth-Dependent Activation of Protein Kinases Suggests a Mechanism for Measuring Cell Growth.

Authors:  Akshi Jasani; Tiffany Huynh; Douglas R Kellogg
Journal:  Genetics       Date:  2020-05-27       Impact factor: 4.562

5.  Spatial regulation of the polarity kinase PAR-1 by parallel inhibitory mechanisms.

Authors:  Andrew W Folkmann; Geraldine Seydoux
Journal:  Development       Date:  2019-03-25       Impact factor: 6.868

6.  The KLDpT activation loop motif is critical for MARK kinase activity.

Authors:  Tim Sonntag; James J Moresco; John R Yates; Marc Montminy
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.